Resultats globals: 2 registres trobats en 0.02 segons.
Articles, 2 registres trobats
Articles 2 registres trobats  
1.
14 p, 1.6 MB Randomized prospective study evaluating tenofovir disoproxil fumarate prophylaxis against hepatitis B virus reactivation in anti- HBc-positive patients with rituximab-based regimens to treat hematologic malignancies: The Preblin study / Buti, María (Hospital Universitari Vall d'Hebron) ; Manzano,María L. (Hospital Universitario 12 de Octubre (Madrid)) ; Morillas Cunill, Rosa Ma. (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; García-Retortillo, Montserrat (Hospital del Mar (Barcelona, Catalunya)) ; Martín, Leticia (Hospital de Donostia (Sant Sebastià, País Basc)) ; Prieto, Martín (Hospital Universitari i Politècnic La Fe de Valencia) ; Gutiérrez García, María Luisa (Fundación Hospital de Alcorcón) ; Suárez, Emilio (Hospital Nuestra Señora de Balme) ; Gómez Rubio, Mariano (Hospital Universitario de Getafe (Madrid)) ; López,Javier (Hospital Ramón y Cajal) ; Castillo, Pilar (Hospital Universitario La Paz (Madrid)) ; Rodríguez,Manuel (Hospital Central de Asturias) ; Zozaya, José M. (Hospital de Navarra) ; Simón, Miguel A. (Hospital Clínico Universitario "Lozano Blesa" de Zaragoza) ; Morano Amado, Luis Enrique (Hospital do Meixoeiro) ; Calleja, José L. (Hospital Puerta de Hierro (Madrid)) ; Yébenes María (Pharmacoeconomics & Outcomes Research Iberia) ; Esteban, Rafael (Esteban Mur) (Hospital Universitari Vall d'Hebron)
Background. Hepatitis B virus (HBV) reactivation in patients with resolved HBV infection (HBsAg negative, antiHBc positive) is uncommon, but potentially fatal. The role of HBV prophylaxis in this setting is uncertain. [...]
2017 - 10.1371/journal.pone.0184550
PloS one, Vol. 12 Núm. 9 (september 2017) , p. 1-14  
2.
13 p, 347.6 KB Prediction of week 4 virological response in hepatitis C for making decision on triple therapy : the Optim study / Romero-Gómez, Manuel (Hospital Universitario Virgen de Valme (Sevilla, Andalusia)) ; Turnes, Juan (Complejo Hospitalario de Pontevedra) ; Ampuero, Javier (Hospital de Valme (Sevilla)) ; Oyagüez, Itziar (Pharmacoeconomics & Outcomes Research IBeria (Madrid)) ; Cuenca, Beatriz (Hospital Universitario Infanta Cristina (Madrid)) ; Gonzalez-García, Juan (Hospital Universitario La Paz (Madrid)) ; Muñoz-Molina, Belén (Roche Farma) ; Aguilar, Rocío (Fisevi (Sevilla)) ; Leal, Sandra (Fisevi (Sevilla)) ; Planas Vilà, Ramon (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Garcia-Samaniego, Javier (Hospital Carlos III (Madrid)) ; Diago, Moisés (Consorci Hospital General Universitari (Valencia)) ; Crespo, Javier (Hospital Universitario Marqués de Valdecilla (Santander, Cantabria)) ; Calleja, Jose Luís (Hospital Universitario Puerta de Hierro Majadahonda (Madrid)) ; Casado, Miguel Ángel (Pharmacoeconomics & Outcomes Research IBeria (Madrid)) ; Solà Lamoglia, Ricard (Hospital del Mar (Barcelona, Catalunya))
Background: Virological response to peginterferon + ribavirin (P+R) at week 4 can predict sustained virological response (SVR). While patients with rapid virological response (RVR) do not require triple therapy, patients with a decline <1log10 IU/ml HCVRNA (D1L) should have treatment discontinued due to low SVR rate. [...]
2015 - 10.1371/journal.pone.0122613
PloS one, Vol. 10, No 3 (March 2015) , p. e0122613  

Vegeu també: autors amb noms similars
2 Calleja, J.A.
1 Calleja, J.L
2 Calleja, J.L.
2 Calleja, Jose Luis
2 Calleja, Jose Luis
2 Calleja, Jose Luís
1 Calleja, José L.
2 Calleja, José Luis
16 Calleja, Juan Antonio
2 Calleja, Juan Antonio,
Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.